Skip to main content
Erschienen in: Surgical Endoscopy 3/2017

05.08.2016

Esophageal stent fixation with endoscopic suturing device improves clinical outcomes and reduces complications in patients with locally advanced esophageal cancer prior to neoadjuvant therapy: a large multicenter experience

verfasst von: Juliana Yang, Ali A. Siddiqui, Thomas E. Kowalski, David E. Loren, Ammara Khalid, Ayesha Soomro, Syed M. Mazhar, Julian Rosé, Laura Isby, Michel Kahaleh, Ankush Kalra, Alex M. Sarkisian, Nikhil A. Kumta, Jose Nieto, Reem Z. Sharaiha

Erschienen in: Surgical Endoscopy | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Endoscopic placement of fully covered self-expanding metal stents (FCSEMS) to treat malignant dysphagia in patients with esophageal cancer significantly improves dysphagia; however, these stents have a high migration rate.

Aim

To determine whether FCSEMS fixation using an endoscopic suturing device treated malignant dysphagia and prevented stent migration in patients with locally advanced esophageal cancer receiving neoadjuvant therapy when compared to patients with FCSEMS placement alone.

Method

A review of patients with locally advanced esophageal cancer who underwent FCSEMS placement at 3 centers was performed. Patients were divided into two groups: Group A (n = 26) was composed of patients who underwent FCSEMS placement with suture placement, and Group B (n = 67) was composed of patients with FCSEMS placement alone.

Results

There were no significant differences between Groups A and B in demographics, and tumor characteristics. The technical success rate for stent placement was 100 %. There was no difference between Groups A and B in the median stent diameter and stent lengths. Mean dysphagia score obtained at 1 week after stent placement had improved significantly from baseline (2.4 and 1, respectively, p < 0.001). Patients had a median follow-up of 4 months. Immediate adverse events were mild chest discomfort in 4 patients in Group A and 2 patients in Group B (p = 0.05), and significant acid reflux in 3 patient in Group A compared to 2 patients in Group B (p = 0.1). The stent migration rate was significantly lower in Group A compared to compared to Group B (7.7 vs 26.9 %, respectively, p = 0.004). There was a delayed perforation in 1 patient and 1 death due to aspiration pneumonia in Group B.

Conclusion

Fixation of esophageal FCSEMSs by using an endoscopic suturing device in patients receiving neoadjuvant therapy was shown to be feasible, safe, and relatively effective at preventing stent migration compared to those who had stent placed alone.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Siddiqui AA, Sarkar A, Beltz S, Lewis J, Loren D, Kowalski T et al (2012) Placement of fully covered self-expandable metal stents in patients with locally advanced esophageal cancer before neoadjuvant therapy. Gastrointest Endosc 76(1):44–51CrossRefPubMed Siddiqui AA, Sarkar A, Beltz S, Lewis J, Loren D, Kowalski T et al (2012) Placement of fully covered self-expandable metal stents in patients with locally advanced esophageal cancer before neoadjuvant therapy. Gastrointest Endosc 76(1):44–51CrossRefPubMed
2.
Zurück zum Zitat Homs MY, Steyerberg EW, Eijkenboom WM, Tilanus HW, Stalpers LJ, Bartelsman JF et al (2004) Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet 364(9444):1497–1504CrossRefPubMed Homs MY, Steyerberg EW, Eijkenboom WM, Tilanus HW, Stalpers LJ, Bartelsman JF et al (2004) Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet 364(9444):1497–1504CrossRefPubMed
3.
Zurück zum Zitat Vlavianos P, Zabron A (2012) Clinical outcomes, quality of life, advantages and disadvantages of metal stent placement in the upper gastrointestinal tract. Curr Opin Support Palliat Care 6(1):27–32CrossRefPubMed Vlavianos P, Zabron A (2012) Clinical outcomes, quality of life, advantages and disadvantages of metal stent placement in the upper gastrointestinal tract. Curr Opin Support Palliat Care 6(1):27–32CrossRefPubMed
4.
Zurück zum Zitat Dua KS, Latif SU, Yang JF, Fang TC, Khan A, Oh Y (2014) Efficacy and safety of a new fully covered self-expandable non-foreshortening metal esophageal stent. Gastrointest Endosc 80(4):577–585CrossRefPubMed Dua KS, Latif SU, Yang JF, Fang TC, Khan A, Oh Y (2014) Efficacy and safety of a new fully covered self-expandable non-foreshortening metal esophageal stent. Gastrointest Endosc 80(4):577–585CrossRefPubMed
5.
Zurück zum Zitat Song HY, Do YS, Han YM, Sung KB, Choi EK, Sohn KH et al (1994) Covered, expandable esophageal metallic stent tubes: experiences in 119 patients. Radiology 193(3):689–695CrossRefPubMed Song HY, Do YS, Han YM, Sung KB, Choi EK, Sohn KH et al (1994) Covered, expandable esophageal metallic stent tubes: experiences in 119 patients. Radiology 193(3):689–695CrossRefPubMed
6.
Zurück zum Zitat Siersema PD, van Hillegersberg R (2008) Treatment of locally advanced esophageal cancer with surgery and chemoradiation. Curr Opin Gastroenterol 24(4):535–540CrossRefPubMed Siersema PD, van Hillegersberg R (2008) Treatment of locally advanced esophageal cancer with surgery and chemoradiation. Curr Opin Gastroenterol 24(4):535–540CrossRefPubMed
8.
Zurück zum Zitat Sharaiha RZ, Kumta NA, DeFilippis EM, Dimaio CJ, Gonzalez S, Gonda T, et al. (2016) A large multicenter experience with endoscopic suturing for Management of gastrointestinal defects and stent anchorage in 122 patients: a retrospective review. J Clin Gastroenterol 50(5):388–392PubMed Sharaiha RZ, Kumta NA, DeFilippis EM, Dimaio CJ, Gonzalez S, Gonda T, et al. (2016) A large multicenter experience with endoscopic suturing for Management of gastrointestinal defects and stent anchorage in 122 patients: a retrospective review. J Clin Gastroenterol 50(5):388–392PubMed
9.
Zurück zum Zitat Haito-Chavez Y, Law JK, Kratt T, Arezzo A, Verra M, Morino M et al (2014) International multicenter experience with an over-the-scope clipping device for endoscopic management of GI defects (with video). Gastrointest Endosc 80(4):610–622CrossRefPubMed Haito-Chavez Y, Law JK, Kratt T, Arezzo A, Verra M, Morino M et al (2014) International multicenter experience with an over-the-scope clipping device for endoscopic management of GI defects (with video). Gastrointest Endosc 80(4):610–622CrossRefPubMed
10.
Zurück zum Zitat Sharaiha RZ, Kim KJ, Singh VK, Lennon AM, Amateau SK, Shin EJ et al (2014) Endoscopic stenting for benign upper gastrointestinal strictures and leaks. Surg Endosc 28(1):178–184CrossRefPubMed Sharaiha RZ, Kim KJ, Singh VK, Lennon AM, Amateau SK, Shin EJ et al (2014) Endoscopic stenting for benign upper gastrointestinal strictures and leaks. Surg Endosc 28(1):178–184CrossRefPubMed
11.
Zurück zum Zitat Cotton PB, Eisen GM, Aabakken L, Baron TH, Hutter MM, Jacobson BC et al (2010) A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc 71(3):446–454CrossRefPubMed Cotton PB, Eisen GM, Aabakken L, Baron TH, Hutter MM, Jacobson BC et al (2010) A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc 71(3):446–454CrossRefPubMed
12.
Zurück zum Zitat Hyngstrom JR, Posner MC (2010) Neoadjuvant strategies for the treatment of locally advanced esophageal cancer. J Surg Oncol 101(4):299–304CrossRefPubMed Hyngstrom JR, Posner MC (2010) Neoadjuvant strategies for the treatment of locally advanced esophageal cancer. J Surg Oncol 101(4):299–304CrossRefPubMed
13.
Zurück zum Zitat Diaz R, Reynes G, Tormo A, de Juan M, Girones R, Segura A et al (2009) Long-term results of neoadjuvant chemotherapy and combined chemoradiotherapy before surgery in the management of locally advanced oesophageal cancer: a single-centre experience. Clin Transl Oncol 11(12):835–841CrossRefPubMed Diaz R, Reynes G, Tormo A, de Juan M, Girones R, Segura A et al (2009) Long-term results of neoadjuvant chemotherapy and combined chemoradiotherapy before surgery in the management of locally advanced oesophageal cancer: a single-centre experience. Clin Transl Oncol 11(12):835–841CrossRefPubMed
14.
Zurück zum Zitat Bakken JC, Song LMWK, de Groen PC, Baron TH (2010) Use of a fully covered self-expandable metal stent for the treatment of benign esophageal diseases. Gastrointest Endosc 72(4):712–720CrossRefPubMed Bakken JC, Song LMWK, de Groen PC, Baron TH (2010) Use of a fully covered self-expandable metal stent for the treatment of benign esophageal diseases. Gastrointest Endosc 72(4):712–720CrossRefPubMed
15.
Zurück zum Zitat Senousy BE, Gupte AR, Draganov PV, Forsmark CE, Wagh MS (2010) Fully covered Alimaxx esophageal metal stents in the endoscopic treatment of benign esophageal diseases. Dig Dis Sci 55(12):3399–3403CrossRefPubMed Senousy BE, Gupte AR, Draganov PV, Forsmark CE, Wagh MS (2010) Fully covered Alimaxx esophageal metal stents in the endoscopic treatment of benign esophageal diseases. Dig Dis Sci 55(12):3399–3403CrossRefPubMed
16.
Zurück zum Zitat Eloubeidi MA, Lopes TL (2009) Novel removable internally fully covered self-expanding metal esophageal stent: feasibility, technique of removal, and tissue response in humans. Am J Gastroenterol 104(6):1374–1381CrossRefPubMed Eloubeidi MA, Lopes TL (2009) Novel removable internally fully covered self-expanding metal esophageal stent: feasibility, technique of removal, and tissue response in humans. Am J Gastroenterol 104(6):1374–1381CrossRefPubMed
17.
Zurück zum Zitat Didden P, Spaander MC, Bruno MJ, Kuipers EJ (2013) Esophageal stents in malignant and benign disorders. Curr Gastroenterol Rep 15(4):319CrossRefPubMed Didden P, Spaander MC, Bruno MJ, Kuipers EJ (2013) Esophageal stents in malignant and benign disorders. Curr Gastroenterol Rep 15(4):319CrossRefPubMed
18.
Zurück zum Zitat Maetani I, Isayama H, Mizumoto Y (2007) Palliation in patients with malignant gastric outlet obstruction with a newly designed enteral stent: a multicenter study. Gastrointest Endosc 66(2):355–360CrossRefPubMed Maetani I, Isayama H, Mizumoto Y (2007) Palliation in patients with malignant gastric outlet obstruction with a newly designed enteral stent: a multicenter study. Gastrointest Endosc 66(2):355–360CrossRefPubMed
19.
Zurück zum Zitat Homann N, Noftz MR, Klingenberg-Noftz RD, Ludwig D (2008) Delayed complications after placement of self-expanding stents in malignant esophageal obstruction: treatment strategies and survival rate. Dig Dis Sci 53(2):334–340CrossRefPubMed Homann N, Noftz MR, Klingenberg-Noftz RD, Ludwig D (2008) Delayed complications after placement of self-expanding stents in malignant esophageal obstruction: treatment strategies and survival rate. Dig Dis Sci 53(2):334–340CrossRefPubMed
20.
Zurück zum Zitat Conio M, Repici A, Battaglia G, De Pretis G, Ghezzo L, Bittinger M et al (2007) A randomized prospective comparison of self-expandable plastic stents and partially covered self-expandable metal stents in the palliation of malignant esophageal dysphagia. Am J Gastroenterol 102(12):2667–2677CrossRefPubMed Conio M, Repici A, Battaglia G, De Pretis G, Ghezzo L, Bittinger M et al (2007) A randomized prospective comparison of self-expandable plastic stents and partially covered self-expandable metal stents in the palliation of malignant esophageal dysphagia. Am J Gastroenterol 102(12):2667–2677CrossRefPubMed
Metadaten
Titel
Esophageal stent fixation with endoscopic suturing device improves clinical outcomes and reduces complications in patients with locally advanced esophageal cancer prior to neoadjuvant therapy: a large multicenter experience
verfasst von
Juliana Yang
Ali A. Siddiqui
Thomas E. Kowalski
David E. Loren
Ammara Khalid
Ayesha Soomro
Syed M. Mazhar
Julian Rosé
Laura Isby
Michel Kahaleh
Ankush Kalra
Alex M. Sarkisian
Nikhil A. Kumta
Jose Nieto
Reem Z. Sharaiha
Publikationsdatum
05.08.2016
Verlag
Springer US
Erschienen in
Surgical Endoscopy / Ausgabe 3/2017
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-016-5131-3

Weitere Artikel der Ausgabe 3/2017

Surgical Endoscopy 3/2017 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.